Joshua Mali, MD, focuses his blog on individualized patient care in a private retina practice setting.

BLOG: Laser still has an important role in diabetic eye disease

January 14, 2019

There is no question that the introduction of anti-VEGF agents has dramatically changed the landscape of how surgeons approach retinal diseases. New drugs continue to…

BLOG: Top five things to know about an innovative drug delivery system for DME

December 6, 2018

Standard therapy for the rising number of patients with diabetic macular edema typically consists of anti-VEGF treatments. However, a significant number of patients…

BLOG: Artificial intelligence in early detection of wet AMD

November 16, 2018

It is crucial that we employ strategies to better detect intermediate age-related macular degeneration so we can begin treatment sooner and preserve functional vision…

BLOG: Putting technology to work for you: Monitoring AMD patients

October 15, 2018

Much of the emphasis in retinal diseases is on current drug treatment regimens, investigating new agents and evaluating potential drug delivery systems. Equally…

BLOG: Telemonitoring allows for earlier detection and timely treatment of AMD

September 18, 2018

Recently, I have predicted that telemedicine is poised to become more routinely used in our management of age-related macular degeneration patients. We know that in…

BLOG: Differentiating steroid uses for individualized patient care and optimal outcomes

August 28, 2018

The most common cause of vision loss in diabetic patients is diabetic macular edema, a disease that continues to grow to epidemic proportions due to the steady rise of…